ArticleEBioMedicine2016

Targeting the PDGF-B/PDGFR-β Interface with Destruxin A5 to Selectively Block PDGF-BB/PDGFR-ββ Signaling and Attenuate Liver Fibrosis.

Xingqi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.